Form 4: Astrana Health COO and CFO Chandan Basho Reports Changes in Beneficial Ownership

Chandan Basho, COO and CFO of Astrana Health, Inc., reports the acquisition of restricted stock units and the surrender of shares for tax obligations.

Summary

• On November 8, 2024, Chandan Basho, the COO and CFO of Astrana Health, Inc., reported changes in beneficial ownership of the company's stock.
• Basho acquired 15,510 shares of common stock through a grant of restricted stock units (RSUs) at a price of $0.
• These RSUs vest in eight equal installments, starting on November 8, 2024, and continuing semi-annually beginning on April 2, 2025, contingent upon continued employment.
• Basho also surrendered 691 shares to cover tax withholding obligations related to vested RSUs at a price of $46.96.
• Following these transactions, Basho beneficially owns 166,051 shares of Astrana Health, Inc.
• This total includes 64,594 unvested restricted shares vesting at various dates in 2025, 2026 and 2027, and 27,303 restricted stock units vesting semi-annually from April 2, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a key executive is generally a good sign, indicating confidence in the company's future. However, the surrender of shares for tax obligations is a neutral event.

Positives

• The grant of restricted stock units to a key executive like the COO and CFO can be seen as a positive sign, aligning their interests with the long-term success of the company.

Negatives

• The surrender of shares to cover tax obligations, while a normal occurrence, slightly reduces the executive's holdings.

Risks

• The vesting of the restricted stock units is contingent upon continued employment, creating a potential risk if the executive were to leave the company before the vesting dates.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the restricted stock units and shares implies a continued commitment from the executive to the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the COO and CFO's continued investment in the company's stock, which can be viewed positively by investors.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units to align management's interests with shareholders.
• The vesting schedule described is fairly standard, with vesting occurring over multiple years contingent upon continued employment.
• Comparing the size of the RSU grant to those of executives at comparable healthcare companies would provide further context.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive sign, aligning management's interests with theirs.
• Employees may see this as a sign of stability and continued investment in the company's leadership.

Key Dates